Provider-related barriers and enablers to the provision of hepatitis C treatment by general practitioners in Scotland: A behaviour change analysis.

Journal of Viral Hepatitis
David WhiteleyPaul Flowers

Abstract

The ease of direct-acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an opportunity to decentralize HCV treatment into community settings. However, the role of non-specialist clinicians in community-based pathways has received scant attention to date. This study examined barriers and enablers to expanding the role of general practitioners (GPs) in HCV treatment provision, using simple behaviour change theory as a conceptual framework. A maximum variation sample of 22 HCV treatment providers, GPs and HCV support workers participated in semi-structured interviews. Data were inductively coded, and the resulting codes deductively mapped into three principal components of behaviour change: capability, opportunity and motivation (COM-B). By this process, a number of provider- and systemic-level barriers and enablers were identified. Key barriers included the pre-treatment assessment of liver fibrosis, GP capacity and the 'speciality' of HCV care. Enablers included the simplicity of the drugs, existing GP/patient relationships and the provision of holistic care. In addition to these specific factors, the data also exposed an overarching provider understanding of 'HCV treatment' as triumvirate in nature, incor...Continue Reading

References

Jun 10, 2009·Family Practice·Sarah CroweJudith A Cantrill
Nov 7, 2013·Administration and Policy in Mental Health·Lawrence A PalinkasKimberly Hoagwood
Oct 19, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I CarmonaM Romero-Gómez
Nov 1, 2018·Hepatology International·Steve JohnsonMichael Schultz
Jan 4, 2019·International Journal of Antimicrobial Agents·Marc Bourlière, Olivia Pietri
Apr 19, 2019·The International Journal on Drug Policy·Beth E WilliamsJonathan Garcia
Apr 24, 2019·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·N ShehataK Timmerman
Oct 22, 2019·Lancet·C Wendy SpearmanMark Sonderup
Nov 2, 2019·Australian Health Review : a Publication of the Australian Hospital Association·Davoud PourmarziGerard FitzGerald
Feb 26, 2020·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Jeremy HorwoodMathew Hickman
Mar 7, 2020·The International Journal on Drug Policy·Oluwaseun Falade-NwuliaShruti H Mehta
May 23, 2020·Alimentary Pharmacology & Therapeutics·Kathryn DrysdaleGraham R Foster
Jun 13, 2020·Journal of Substance Abuse Treatment·Leith MorrisAndrew Smirnov

❮ Previous
Next ❯

Citations

May 29, 2021·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Helen Jarvis, David Whiteley
Jul 31, 2021·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Elizabeth M SpeakmanDavid Whiteley

❮ Previous
Next ❯

Methods Mentioned

BETA
blood draws
PCR

Software Mentioned

COM
NVivo

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.